Brief: Checkpoint Therapeutics Reports Q3 Loss Per Share Of $0.14

Checkpoint Therapeutics

04/11/2021 22:37

Nov 4 (Reuters) - Checkpoint Therapeutics Inc  CKPT.O :
    * CHECKPOINT THERAPEUTICS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.14
    * AS OF SEPT 30, 2021, CHECKPOINT'S CASH AND CASH
EQUIVALENTS
TOTALED $60.2 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.14 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5bqnky 
Further company coverage:  CKPT.O 

 ((Reuters.Briefs@thomsonreuters.com;))